Drawbridge pharmaceuticals pty ltd
WebGraeme Wald, B.SC Hons. PhD. MBA. GAICD, Chief Executive Officer. Graeme is an Industrial Chemist and has worked as a research chemist in South Africa, Israel and the USA. He became an equities analyst and while at Merril Lynch was rated the top analyst in the Pharmaceuticals and Healthcare sector in South Africa and was a member of the … WebDrawbridge Pharmaceuticals Pty Ltd n/a Founded 2011 Australia Drawbridge Pharmaceuticals is a privately-held company developing neuroactive steroid compounds for use in critical care situations. The properties of these compounds include anaesthesia and sedation, anticonvulsant activity and neuroprotection.
Drawbridge pharmaceuticals pty ltd
Did you know?
WebJan 26, 2024 · Description. Drawbridge Pharmaceuticals Pty Ltd is a limited by shares … WebAssignee: DRAWBRIDGE PHARMACEUTICALS PTY LTD Inventors: Ian Edmonds, Edward J. Hessler Anaesthetic formulation. Patent number: 8975245 Abstract: The present invention relates generally to the field of drug delivery systems for neuroactive steroid anaesthetic agents. More particularly, anaesthetic and sedative formulations are …
WebDrawbridge was founded in 2011. It is a privately-held company headquartered in … WebDrawbridge Corporate Governance Policy 2016 . Our Approach to Corporate …
WebLocation: Australia Founded in 2011 "Drawbridge Pharmaceuticals is a privately-held company developing neuroactive steroid compounds for use in critical care situations. The properties of these compounds include anaesthesia and sedation, anticonvulsant activity and neuroprotection." Description Source: Bio tech-Careers WebFOUNDERS - Drawbridge Pharmaceuticals FOUNDERS Juliet Serrao MB, BS, PhD, FRCA, GAICD Juliet is the inventor of the Phaxan® technology, and co‐founder of Drawbridge. She has been a key person in the research and development of Phaxan® from the early concept to late stage clinical development.
WebSep 15, 2014 · MELBOURNE, AUSTRALIA: September 15, 2014—Drawbridge Pharmaceuticals Pty Ltd (Drawbridge) is pleased to announce that it will be presenting the results of the first in human study of Phaxan™ at Anesthesiology™ 2014 in New Orleans, LA. Oral and poster presentations will be delivered by Professor Colin …
WebDrawbridge was founded in 2011. It is a privately-held company headquartered in Melbourne, Australia. Drawbridge is developing neuroactive steroid compounds for use in critical care situations in which protection of the brain from insult is required. map of gloucestershire and wiltshireWebDrawbridge Pharmaceuticals Pty Ltd is a Drug Manufacturing & Research, Biotechnology, and Pharmaceuticals company located in Malvern, Victoria with $1.00 Million in revenue and 3 employees. Find top employees, contact details and business statistics at … kroger cypress north houston jones roadWebApr 16, 2014 · MELBOURNE, AUSTRALIA: April 16, 2014—Drawbridge Pharmaceuticals Pty Ltd (Drawbridge) is pleased to announce that it has completed a Phase 1C clinical trial of Phaxan™ - alphaxalone dissolved in sulfobutyl ether beta cyclodextrin (SBEßCD). The randomised, double blind dose finding study using a Bayesian design was conducted to … kroger cypresswood and 290WebDrawbridge Pharmaceuticals Pty Ltd is a Drug Manufacturing & Research, … kroger customer survey and feedbackWebOct 28, 2013 · October 28, 2013 -- Drawbridge Pharmaceuticals Pty Ltd (Drawbridge) … kroger daily probioticWebDrawbridge is a privately-held company head quartered in Melbourne, Australia. Drawbridge is developing neuroactive steroid compounds for … map of gloucestershire showing villagesWebPHAXAN is a united kingdom trademark and brand of Drawbridge Pharmaceuticals Pty Ltd, AUSTRALIA. This trademark was filed to UKIPO on Tuesday, January 10, 2012. The PHAXAN is under the trademark classification: Pharmaceutical Products; The PHAXAN trademark covers Anaesthetics, sedatives, anticonvulsants for use in the treatment of … kroger daily express pay